Actively Recruiting
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
Led by Tanta University · Updated on 2021-03-10
300
Participants Needed
1
Research Sites
545 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Efficacy of Ivermectin in larger doses in COVID-19 treatment
CONDITIONS
Official Title
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with covid 19
You will not qualify if you...
- Allergy or side effects to treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, Egypt, 35111
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here